InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Kelly Leanne M., Chief Financial Officer. Director active across 1 companies, notably Vallon Pharmaceuticals, Inc.. In total, 2 filings have been published. Total volume traded: €24k. The latest transaction was filed on 2 June 2021 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
€11,9803,657 shares@ €3.276100.0% of flow
Common Stock
SEC:0001104659-21-076998·
Ideal exit: 27 Feb 2022 (T+270)
€11,9803,657 shares@ €3.27650.0% of flow
Common Stock
SEC:0001104659-21-076998:0·
Ideal exit: 27 Feb 2022 (T+270)
2 of 2 declarations
About Kelly Leanne M.
Leanne M. Kelly is the Chief Financial Officer of Vallon Pharmaceuticals, Inc. She is responsible for the financial management of the company, including budgeting and financial performance analysis. Her role is essential in ensuring Vallon's financial health and supporting its strategic initiatives. Leanne also contributes to the development of the company's overall financial strategy.
